Condition: Obesity · Overweight · Sponsor: Eli Lilly and Company
The main purpose of this study, performed under Master Protocol J4M-MC-PWMP (NCT06672549), is to evaluate the efficacy, safety, and pharmacokinetics of orforglipron once daily oral versus Placebo in adolescent participants with obesity, or overweight with related comorbidities. Participation in the study will last about 18 months. Participants who have completed the primary PW01 study (including the 4-week safety follow-up period) will have the opportunity to receive an additional 156 weeks of treatment with orforglipron as well as continuing the lifestyle intervention.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Carey Chronis MD Pediatric, Infant and Adolescent Medicine | Ventura, California, United States | Active Not Recruiting |
| Stamford Therapeutics Consortium | Stamford, Connecticut, United States | Active Not Recruiting |
| Children's Healthcare of Atlanta - Center for Advanced Pediatrics | Atlanta, Georgia, United States | Active Not Recruiting |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago, Illinois, United States | Active Not Recruiting |
| Velocity Clinical Research | Lafayette, Louisiana, United States | Active Not Recruiting |
| MedPharmics, LLC | Gulfport, Mississippi, United States | Recruiting |
| Sundance Clinical Research | St Louis, Missouri, United States | Active Not Recruiting |
| Lucas Research, Inc. | Morehead City, North Carolina, United States | Active Not Recruiting |
| Childrens Hospital of Pittsburgh | Pittsburgh, Pennsylvania, United States | Active Not Recruiting |
| Vanderbilt Health One Hundred Oaks | Nashville, Tennessee, United States | Active Not Recruiting |
| Dynamed Clinical Research, LP d/b/a DM Clinical Research | Houston, Texas, United States | Active Not Recruiting |
| La Providence Pediatrics Clinic - Chemidox Clinical Trials | Houston, Texas, United States | Active Not Recruiting |
+ 26 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06672939